Effect of ERAS on duration of hospital stay in patients undergoing surgery for oral cancers.

Effect of Enhanced Recovery After Surgery on Length of hospital stay among patients undergoing surgery for Oral cancers- A Randomized Controlled trial - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/07/071183

Enrollment

108

Registered

2024-07-24

Start date

Unknown

Completion date

Unknown

Last updated

2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K137- Other and unspecified lesions of oral mucosa

Interventions

Intervention1: ERAS group: Patients with Oral cancers undergoing surgery received ERAS based Preoperative, Intraoperative and Postoperative care will assessed for 30 days after surgery. Intervention2:

Eligibility

Inclusion criteria

Inclusion criteria: 1)Adult Population aged 18 years and above 2)Diagnosed case of Oral cancers undergoing surgery 3)ECOG Performance Status of 0 to 2

Exclusion criteria

Exclusion criteria: 1. Free Osteocutaneous flaps taken from lower limbs. 2. Use of multiple (2 and above) regional/distant flaps and central Mandibulectomy 3. Post radiation therapy 4. Salvage surgery for residual/recurrent disease 5. Patients with Renal and Liver decompensation 6. Not consenting for the study

Design outcomes

Primary

Measure	Time frame
To assess the effect of ERAS on LOS among the patients with Oral cancers undergoing surgeryTimepoint: Duration of total hospital stay will assessed at 30 days after surgery.	—

Secondary

Measure	Time frame
To compare the mean ICU stay, morbidity & mortality & 30-day readmission rateTimepoint: Outcomes will be assessed till postoperative day 30	—

Countries

India

Contacts

Public ContactBalasubramanian A

JIPMER, Puducherry

drbalasubram@gmail.com9445216149

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026